Abstract
Out of 2580 medical inpatients included in a drug-surveillance programme, 585 (22.7%) were treated with frusemide. Of these, 123 (21.0%) had a total of 177 adverse reactions. The most common were hypovolaemia (85 cases), hyperuricaemia (54), and hypokalaemia (21). Most reactions were mild, and only three patients had potentially life-threatening effects. The incidence of adverse reactions increased significantly with daily dose, occurring in 47 patients (13.5%) given up to 40 mg, 42 (26.3%) given up to 80 mg, and 34 (43.6%) given over 80 mg (P less than 0.001). There was no clear association between side effects and a raised blood urea concentration on admission, confirming that treatment with frusemide is not more hazardous in patients with renal failure. Frusemide is a safe and highly effective diuretic. Nevertheless, in view of the potential seriousness of volume depletion, dosage should probably begin at 20 rather than 40 mg daily.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Kassirer J. P., Harrington J. T. Diuretics and potassium metabolism: a reassessment of the need, effectiveness and safety of potassium therapy. Kidney Int. 1977 Jun;11(6):505–515. doi: 10.1038/ki.1977.67. [DOI] [PubMed] [Google Scholar]
- Kennedy A. C., Lyell A. Acquired epidermolysis bullosa due to high-dose frusemide. Br Med J. 1976 Jun 19;1(6024):1509–1510. doi: 10.1136/bmj.1.6024.1509. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lawson D. H., Boddy K., Gray J. M., Mahaffey M., Mills E. Potassium supplements in patients receiving long-term diuretics for oedema. Q J Med. 1976 Jul;45(179):469–478. [PubMed] [Google Scholar]
- Steele T. H. Evidence for altered renal urate reabsorption during changes in volume of the extracellular fluid. J Lab Clin Med. 1969 Aug;74(2):288–299. [PubMed] [Google Scholar]